These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Tamoxifen therapy in premenopausal women with metastatic breast cancer.
    Author: Planting AS, Alexieva-Figusch J, Blonk-vdWijst J, van Putten WL.
    Journal: Cancer Treat Rep; 1985 Apr; 69(4):363-8. PubMed ID: 3995508.
    Abstract:
    Forty-three premenopausal women with metastatic breast cancer were treated with tamoxifen (2 X 20 mg daily) as first-line treatment. The patients were not selected on receptor status, which was known in only a few patients. Complete response was achieved in six patients and partial response was achieved in seven patients, for a total response rate of 30%. At the time of disease progression (including nonresponding patients), castration was performed as second-line treatment in 24 patients. Four of eight responders to tamoxifen had a response to castration. Of four patients with stable disease receiving tamoxifen, one had a response, and of 12 patients failing to respond to tamoxifen, one had a complete response and one had a partial response. In conclusion, patients who respond to tamoxifen have a good chance of responding to castration; an initial failure to tamoxifen does not exclude the possibility of response to castration. Therefore, the prognostic value of the tamoxifen response for castration response is of limited value.
    [Abstract] [Full Text] [Related] [New Search]